RA CAPITAL MANAGEMENT, L.P. purchased 208.0% of their position (2.27M shares) of CIDARA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $100.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/30/2025ACC: 0001415889-25-018516
Director
Since Apr 2024
+2.27M
Net shares
Net buyer
$100.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.27M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+2.27M
Price / share
$44.00
Trade value
$100M
% of position
208.0%
6/26/2025
1.09M→3.37M
Total
Net shares
+2.27M
Net value
$100M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/26/2025 | P · Purchase | +2.27M | $44.00 | $100M | 208.0% | 1.09M | 3.37M |
| Total | +2.27M | $100M | ||||||
Derivative Transactions0
No derivative transactions reported